120 related articles for article (PubMed ID: 37052432)
1. The estrogen/miR-338-3p/ADAM17 axis enhances the viability of breast cancer cells via suppressing NK cell's function.
Shi Y; Pan J; Hang C; Tan L; Hu L; Yan Z; Zhu J
Environ Toxicol; 2023 Jul; 38(7):1618-1627. PubMed ID: 37052432
[TBL] [Abstract][Full Text] [Related]
2. LINC00261/microRNA-550a-3p/SDPR axis affects the biological characteristics of breast cancer stem cells.
Li Y; Wu C
IUBMB Life; 2021 Jan; 73(1):188-201. PubMed ID: 33274565
[TBL] [Abstract][Full Text] [Related]
3. Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells
Pham DH; Kim JS; Kim SK; Shin DJ; Uong NT; Hyun H; Yoon MS; Kang SJ; Ryu YJ; Cho JS; Yoon JH; Lee JS; Cho D; Lee SH; Park MH
Anticancer Res; 2017 Oct; 37(10):5507-5513. PubMed ID: 28982863
[TBL] [Abstract][Full Text] [Related]
4. Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer.
Liu Y; Li M; Fang Z; Gao S; Cheng W; Duan Y; Wang X; Feng J; Yu T; Zhang J; Wang T; Hu A; Zhang H; Rong Z; Shakila SS; Shang Y; Kong F; Liu J; Li Y; Ma F
Cancer Immunol Immunother; 2024 May; 73(7):117. PubMed ID: 38713229
[TBL] [Abstract][Full Text] [Related]
5. miRNA-506-3p Directly Regulates rs10754339 (A/G) in the Immune Checkpoint Protein B7-H4 in Breast Cancer.
El Din GS; Youness RA; Assal RA; Gad MZ
Microrna; 2020; 9(5):346-353. PubMed ID: 33297930
[TBL] [Abstract][Full Text] [Related]
6. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
Shi J; Tan S; Song L; Song L; Wang Y
Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancer.
Zamarbide Losada JN; Sulpice E; Combe S; Almeida GS; Leach DA; Choo J; Protopapa L; Hamilton MP; McGuire S; Gidrol X; Bevan CL; Fletcher CE
J Endocrinol; 2023 Mar; 256(3):. PubMed ID: 36622663
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-induced miR-196a elevation promotes tumor growth and metastasis via targeting SPRED1 in breast cancer.
Jiang CF; Shi ZM; Li DM; Qian YC; Ren Y; Bai XM; Xie YX; Wang L; Ge X; Liu WT; Zhen LL; Liu LZ; Jiang BH
Mol Cancer; 2018 Apr; 17(1):83. PubMed ID: 29685157
[TBL] [Abstract][Full Text] [Related]
9. Estrogen regulates miRNA expression: implication of estrogen receptor and miR-124/AKT2 in tumor growth and angiogenesis.
Jiang CF; Li DM; Shi ZM; Wang L; Liu MM; Ge X; Liu X; Qian YC; Wen YY; Zhen LL; Lin J; Liu LZ; Jiang BH
Oncotarget; 2016 Jun; 7(24):36940-36955. PubMed ID: 27175587
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA hsa_circ_0043278 inhibits breast cancer progression via the miR-455-3p/EI24 signalling pathway.
Shi Y; Liu C
BMC Cancer; 2021 Nov; 21(1):1249. PubMed ID: 34800978
[TBL] [Abstract][Full Text] [Related]
11. miR-4299 inhibits tumor progression in pancreatic cancer through targeting ADAM17.
Liu J; Ye L; Lin K; Zhong T; Luo J; Wang T; Suo L; Mo Q; Li S; Chen Q; Yu Y
Mol Cell Biochem; 2023 Aug; 478(8):1727-1742. PubMed ID: 36565360
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression.
Zhu J; Zou Z; Nie P; Kou X; Wu B; Wang S; Song Z; He J
Cell Death Dis; 2016 Nov; 7(11):e2454. PubMed ID: 27809310
[TBL] [Abstract][Full Text] [Related]
13. Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.
Sun T; Song Y; Yu H; Luo X
Cancer Biol Ther; 2019; 20(6):760-773. PubMed ID: 30810442
[TBL] [Abstract][Full Text] [Related]
14. Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells.
Yu X; Zhang X; Dhakal IB; Beggs M; Kadlubar S; Luo D
BMC Cancer; 2012 Jan; 12():29. PubMed ID: 22260523
[TBL] [Abstract][Full Text] [Related]
15. An induction of microRNA, miR-7 through estrogen treatment in breast carcinoma.
Masuda M; Miki Y; Hata S; Takagi K; Sakurai M; Ono K; Suzuki K; Yang Y; Abe E; Hirakawa H; Ishida T; Suzuki T; Ohuchi N; Sasano H
J Transl Med; 2012 Sep; 10 Suppl 1(Suppl 1):S2. PubMed ID: 23227519
[TBL] [Abstract][Full Text] [Related]
16. HDAC3 increases HMGB3 expression to facilitate the immune escape of breast cancer cells via down-regulating microRNA-130a-3p.
Chen Z; Pei L; Zhang D; Xu F; Zhou E; Chen X
Int J Biochem Cell Biol; 2021 Jun; 135():105967. PubMed ID: 33727043
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-519a-3p mediates apoptosis resistance in breast cancer cells and their escape from recognition by natural killer cells.
Breunig C; Pahl J; Küblbeck M; Miller M; Antonelli D; Erdem N; Wirth C; Will R; Bott A; Cerwenka A; Wiemann S
Cell Death Dis; 2017 Aug; 8(8):e2973. PubMed ID: 28771222
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-3613-3p functions as a tumor suppressor and represents a novel therapeutic target in breast cancer.
Chen C; Pan Y; Bai L; Chen H; Duan Z; Si Q; Zhu R; Chuang TH; Luo Y
Breast Cancer Res; 2021 Jan; 23(1):12. PubMed ID: 33494814
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer.
Piperigkou Z; Franchi M; Götte M; Karamanos NK
Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712
[TBL] [Abstract][Full Text] [Related]
20. miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer.
Tian X; Zhang Z
IUBMB Life; 2018 Jan; 70(1):71-80. PubMed ID: 29247596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
